Rapamycin inhibits compensatory bile duct growth after ischemic injury
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To explore the impact of rapamycin on compensatory bile duct growth in response to ischemic injury.Methods: Male SD rats were randomly assigned to 4 groups:sham (n=28),sham+rapamycin ( rapa,n=28 ),ischemia (n=32),ischemia+rapa group (n=32).Complete hepatic arterial deprivation was performed in the latter 2 groups; gastric lavage with rapamycin (2 mg/kg/day ) was given to rats in rapa groups.Fresh liver tissues were obtained on day 1,3,7,and 14 postoperatively and were subjected to immunohistochemical staining (H-E,Ki-67).Interlobular bile duct within portal tract and periportal bile ductuli were counted in H-E stained sections.Ki-67 positive and negative bile duct epithelial cells were counted in Ki-67 immunolabelled sections.Average interlobular ducts,periportal duculi and ratio of Ki-67 positive epithelial cells/negative epithelial cells were calculated.Results: Ischemia group had obviously increased number of interlobular ducts compared to sham group.Rapamycin lavage inhibited interlobular duct increase on day 7 and day 14 postoperatively compared with ischemia group.In ischemia group Ki-67(+)/(-) ratio reached its peak level (1.59±017) 3 days after operation,being significantly higher than that of sham group.Rapamycin decreased the peak value of Ki-67(+)/(-) ratio.Conclusion: Rapamycin can reduce expression of Ki-67 antigen and inhibit compensatory bile duct proliferation in response to ischemic injury.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 28,2007
  • Revised:April 25,2008
  • Adopted:April 28,2008
  • Online: July 16,2008
  • Published:
Article QR Code